Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients
Clinical trial NCT03857165 · COMPLETED
Trial details
- NCT number
- NCT03857165
- Sponsor
- Shanton Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2019-06-02
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.